Clerico, M., Schiavetti, I., De Mercanti, S.F., Piazza, F., Gned, D., Brescia Morra, V., et al. (2014). Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). JAMA NEUROLOGY, 71(71:8), 954-960 [10.1001/jamaneurol.2014.1200.].
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).
SALEMI, Giuseppe;REALMUTO, Sabrina;
2014-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2014 Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab.pdf
accesso aperto
Descrizione: Articolo principale
Dimensione
205.54 kB
Formato
Adobe PDF
|
205.54 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
